FINE CHEMICALS/BIOTECH

HIV Drug Availability and Potential Manufacturing Opportunities

February 2, 2010 | Girish Malhotra

Global spread of HIV/AIDS has been and is a cause of alarm. Approximately 33.4 million people are estimated to be infected with HIV/AIDS and about 30% of this population can use the antiretroviral therapy (ART). Of this number about 42% are getting the...


Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com
MORE FINE CHEMICALS/BIOTECH

Siegfried Merges API and Formulation Divisions

Siegfried (Zofingen, Switzerland), a mid-size fine chemicals group, says from March 1 it will replace its two-division structure featuring active pharmaceutical ingredients (API), and final dosage formulations, with a single division structure. The company...

Tata Chemicals Reports Rise in Third-Quarter Profits; to Expand Urea Capacity

Tata Chemicals (Mumbai) recorded a more than doubling in net profits for its fiscal third quarter ended December 31, 2009 to Rs2.12 billion ($46 million) compared with the year-ago period. Sales decreased 28%, to Rs26.5 billion, however. In the fertilizers...

Carbogen Amcis Opens HPAPI Facility in India

Carbogen Amcis (Bubendorf, Switzerland), a subsidiary of Dishman Pharmaceuticals and Chemicals (Ahmedabad, India) says it has opened its previously announced new high-potency active pharmaceutical ingredient (HPAPI) facility at Dishman’s Bavla site near...

Lonza Struggles in the Face of Lower Demand (update)

Fine chemicals group Lonza says its Ebitda for full year 2009 fell 4.8% to SF 658 million ($626 million) on corresponding sales down 8.4% to SF2.7 billion. The company says it experienced lower demand across all of its businesses. Despite...

Trends in the Manufacturing of Viral Gene Therapeutics and Next Generation Vaccines

Jeff Strobel, Site Director, Sigma Aldrich Fine Chemicals (SAFC; Carlsbad, CA) outlines...

Wacker Records Lower Quarterly Profits, Full-Year Loss

Wacker Chemie reported fourth-quarter 2009 Ebitda of €90 million ($127 million), down from €118.7 million for the period one year earlier. Corresponding sales for the quarter were €935 million, down from €998.7 million one year earlier...

Scandinavia to Develop a Lysine-from-Methanol Process

Bioengineer Trygve Brautaset, a researcher at Sintef Group (Trondheim, Norway), Scandinavia’s largest independent research organisation, has been awarded NK11 million ($1.9 million) to develop a low-cost process for manufacturing lysine from methanol...

Start-up Commissions First Commercial Biosuccinic Acid Plant

Bioamber (Pomacle, France), a three year old joint venture between DNP Green Technology (Princeton, NJ) and (Agro-industrie Recherches et Développements (ARD; Pomacle), an agricultural technology group, says it has successfully begun operating the...

Merck KGaA Builds Pharmaceutical Raw Materials Plant at Darmstadt

Merck KGaA has begun construction work at its Darmstadt, Germany site on a plant for the manufacture of inorganic salts. The company is investing some €30 million ($42.8 million) in the plant, which will produce active ingredients and...

Fine Chemicals/Biotech Archives »

THIS ISSUE

Chemical Week Magazine cover 










 
CONTACT US | CUSTOMER CARE | RSS | PRIVACY POLICY | SITEMAP | ADVERTISE WITH US

Copyright © 2010 Access Intelligence LLC Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa